Kaleido Biosciences Inc. (KLDO)
NASDAQ · Healthcare
Kaleido Biosciences Inc. Total Liabilities 2016–2021
Kaleido Biosciences Inc. annual total liabilities history from 2016 to 2021. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Kaleido Biosciences Inc. total liabilities as of December 31, 2021: 39.5M, a 1.76% increase year-over-year.
- Kaleido Biosciences Inc. total liabilities for 2021 were 39.5M, a 1.76% increase from 2020.
- Kaleido Biosciences Inc. total liabilities for 2020 were 38.8M, a 16.23% increase from 2019.
- Kaleido Biosciences Inc. total liabilities for 2019 were 33.4M, a 81.59% decrease from 2018.
- Kaleido Biosciences Inc. total liabilities for 2018 were 181.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Kaleido Biosciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2021 | $40 |
| 2020 | $39 |
| 2019 | $33 |
| 2018 | $182 |
| 2017 | $74 |
| 2016 | $22 |
Kaleido Biosciences Inc. Total Liabilities — FAQ
Kaleido Biosciences Inc. (KLDO) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KLDO's total liabilities history?
The chart and table above show Kaleido Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.